Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update

Apollomics, Inc. (NASDAQ:APLMW) saw a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 52,500 shares, a growth of 16.7% from the March 15th total of 45,000 shares. Based on an average daily volume of 17,900 shares, the short-interest ratio is currently 2.9 days.

Hedge Funds Weigh In On Apollomics

Hedge funds have recently added to or reduced their stakes in the company. Ionic Capital Management LLC acquired a new position in Apollomics in the first quarter worth approximately $30,000. Shaolin Capital Management LLC acquired a new position in Apollomics in the first quarter worth approximately $33,000. Finally, ATW Spac Management LLC acquired a new position in Apollomics in the first quarter worth approximately $39,000.

Apollomics Stock Performance

Shares of APLMW remained flat at $0.01 during trading hours on Monday. The stock’s 50-day simple moving average is $0.03 and its two-hundred day simple moving average is $0.03. Apollomics has a 1 year low of $0.01 and a 1 year high of $0.13.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.